Joint Transnational Call (JTC) 2025 "Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation"
Basic Information
| Network | ERDERA | ||||||||
| Website | https://erdera.org/news/erdera-pre-announces-2025-joint-transnational-call-for-proposals-on-rare-disease-therapies/ | ||||||||
| Aim of the joint call | The primary objective is to support interdisciplinary, transnational collaborations that leverage complementary expertise to develop new therapies for rare diseases. Research projects should focus on pre-clinical studies involving small molecules or biologicals. This could include the development of novel therapies, biomarkers for therapy efficiency, or replication of pre-clinical studies to validate findings. | ||||||||
| Type of joint call | Two Stages - Call with pre-proposals and full proposals submissions | ||||||||
| Events |
|
||||||||
| Is call co-funded? | No | ||||||||
| Call follow up funding | n/a | ||||||||
| Call reasons | n/a | ||||||||
| Research fields |
|
||||||||
| Type of research | n/a | ||||||||
| Target groups |
|
||||||||
| Participating networks | n/a |